SUSAN KOLB: Open Payments
NPI 1053938340 · VERONA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,639 in 53 payments from 15 companies in 2025. Trend: 2023 $1,969 · 2024 $2,793 · 2025 $1,639
Food & beverage: $1,639
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $472 |
| Janssen Biotech, Inc. | 5 | $232 |
| Lilly USA, LLC | 8 | $220 |
| Madrigal Pharmaceuticals | 2 | $219 |
| GENZYME CORPORATION | 1 | $99 |
| PFIZER INC. | 5 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| Gilead Sciences, Inc. | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, SKYRIZI, OMVOH, SARCLISA, ENTYVIO, VELSIPITY.
Industry payments across NY — which companies pay providers there.
